Dave Herman passed his mandatory pre-fight drug test and will fight as expected at UFC 162.

Nevada Athletic Commission Executive Director Keith Kizer verified Herman’s drug test results with Sherdog.com on Tuesday. The heavyweight was suspended for six months by the UFC after testing positive for marijuana in October, marking the second time Herman was flagged for cannabis use. The 28-year-old was required to undergo treatment and pass the aforementioned 10-panel drug test before he could return to action.

Herman will face Gabriel Gonzaga during Saturday night’s FX-broadcast preliminary card, which immediately precedes the pay-per-view offering. UFC 162 takes place at MGM Grand Garden Arena in Las Vegas and is headlined by a middleweight title confrontation between longtime champion Anderson Silva and unbeaten challenger Chris Weidman.

An EliteXC, Bellator and Sengoku veteran, Herman made his Octagon debut in 2011, stopping decorated grappler John Olav Einemo on second-round strikes at UFC on Fuel TV 1. Three straight losses would follow for Herman, however, as he was knocked out by Stefan Struve and Roy Nelson before submitting to an Antonio Rodrigo Nogueira armbar last year at UFC 153.

view original article >>

Report here if this news is invalid.

Related News

Kimbo Slice Negotiates Steroid Settlement for Failed Drug Test in Texas

  • 27 days ago
  • 22 views

Kimbo Slice and his camp negotiated a lesser punishment with Texas for his Bellator 149 drug test that revealed steroids in his system. read news >>

Bellator Fighter Jordan Parsons, 25, Dies Following Hit-and-Run Incident

  • 25 days ago
  • 73 views

Bellator featherweight fighter Jordan Parsons, a victim of a hit-and-run incident on Sunday, passed away on Wednesday. read news >>

Jeremy Stephens Video: Facts are Renan Barao’s Camp is Losing Since USADA Drug Testing

  • a day ago
  • 27 views

Heading into his showdown with Renan Barao, Jeremy Stephens didn't accuse the Brazilian fighter of outright doping in the past, but the insinuation was there. read news >>